Notifications
- 2019.10.01Establishment of a new cosmetics company
- 2019.03.14CytoReason and Summit Pharmaceuticals International Forge Commercial Alliance To Bring CytoReason’s Machine Learning Model of the Immune System for Drug Discovery & Development To Japanese Drug Makers
- 2018.09.28Sumitomo Corporation Group Statement for UK Modern Slavery Act 2015 (FY 2017 Statement)
- 2017.10.11Sumitomo Corporation Group Statement for UK Modern Slavery Act 2015 (FY 2016 Statement)
- 2016.06.14Successful Identification of Metabolite Differences in Urine between Healthy, Breast Cancer and Colorectal Cancer Groups
- 2016.03.29TRANSFER OF BUSINESS FROM SUMMIT PHARMACEUTICALS INTERNATIONAL TO SUMITOMO CORPORATION
- 2015.04.13Sumitomo Group to Advance into Cosmetic Materials Business in Europe -Acquiring Cosmetic Materials Business from Kyowa Hakko Europe GmbH-
- 2014.10.01Announcement of Business Transfer from Sumitomo Corporation to Summit Pharmaceuticals International Corporation